In-soo Jang

Sorbus alnifolia protects dopaminergic neurodegeneration in Caenorhabditis elegans

Abstract Context: The twigs of Sorbus alnifolia (Sieb. et Zucc.) K. Koch (Rosaceae) have been used to treat neurological disorders as a traditional medicine in Korea. However, there are limited data describing the efficacy of S. alnifolia in Parkinson’s disease (PD). Objective: This study was conducted to identify the protective effects of the methanol extracts of S. alnifolia (MESA) on the dopaminergic (DA) neurodegeneration in Caenorhabditis elegans. Materials and methods: To test the neuroprotective action of MESA, viability assay was performed after 48 h exposure to 1-methyl-4-phenylpyridine (MMP+) in PC12 cells and C. elegans (400 μM and 2 mM of MMP+, respectively). Fluorescence intensity was quantified using transgenic mutants such as BZ555 (Pdat-1::GFP) and and UA57 (Pdat-1::GFP and Pdat-1::CAT-2) to determine MESA’s effects on DA neurodegeneration in C. elegans. Aggregation of α-synuclein was observed using NL5901 strain (unc-54p::α-synuclein::YFP). MESA’s protective effects on the DA neuronal functions were examined by food-sensing assay. Lifespan assay was conducted to test the effects of MESA on the longevity. Results: MESA restored MPP+-induced loss of viability in both PC12 cells and C. elegans (85.8% and 54.9%, respectively). In C. elegans, MESA provided protection against chemically and genetically-induced DA neurodegeneration, respectively. Moreover, food-sensing functions were increased 58.4% by MESA in the DA neuron degraded worms. MESA also prolonged the average lifespan by 25.6%. However, MESA failed to alter α-synuclein aggregation. Discussion and conclusions: These results revealed that MESA protects DA neurodegeneration and recovers diminished DA neuronal functions, thereby can be a valuable candidate for the treatment of PD.

A Review Study of Scalp Acupuncture for Parkinson's Disease in China

Objectives : The purpose of this study was to obtain some knowledge about the scalp acupuncture treatment on Parkinson`s disease for the future practice and the research from the clinical studies in China. Methods : The literatures were searched using the database-China Academic Journals(CAJ) (2006-2011). Clinical studies of scalp acupuncture for Parkinson`s disease-Randomized controlled trial(RCT), case control study, case series, case report- were included. Results : Of 65 articles, 12 Clinical studies met our inclusion criteria. Three case series reported a significant improvement in the patients with Parkinson`s disease by scalp acupuncture, and 9 RCTs reported a significant effectiveness of scalp acupuncture as a monotherapy or as a combination therapy with Madopa Tablet(Levodopa + Benserazide HCl) treatment. Conclusions : The results of this study could be used for the future study about scalp acupuncture for Parkinson`s disease.